Richard Mello
Family · Schertz, TXNPI 1801539622
Payments from drug & device makers
Across 44 payments — averaging $32.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$235
- GSK$137
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$128
- AstraZeneca$125
- Smith+Nephew$119
- Bioventus LLC$110
- plus $572 from 16 others
What the payments were for
- Food & beverage$1,426100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 11 | $235 |
| GSK | 2 | $137 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $128 |
| AstraZeneca | 1 | $125 |
| Smith+Nephew | 1 | $119 |
| Bioventus LLC | 3 | $110 |
| Argenx US, Inc. | 1 | $99 |
| ERMI LLC | 1 | $83 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $73 |
| Merck | 3 | $48 |
| AbbVie | 2 | $44 |
| Shield Therapeutics Inc | 2 | $33 |
| Lilly USA, LLC | 2 | $31 |
| Novartis | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Almatica Pharma LLC | 1 | $15 |
| Corium, LLC | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Novo Nordisk | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$125
- FASENRA$125
- ALLEVYN HEEL 10.5CM X 13.5CM CTN 5$119
- Iodosorb Ointment 40g USA$119
- COLLAGENASE SANTYL$119
- Oasis$119
- TC-100$119
- CAPLYTA$115
How this compares
$1,426 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.
Other family in Schertz
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.